LeadingTac

Shanghai, China · Founded 2019 · Privately Held (backing)

Developer of small-molecule innovative therapeutics intended for the treatment of autoimmune and tumor diseases. LeadingTac is based in Shanghai, China and was founded in 2019. Its last reported valuation was $8.5 million in Nov 2019. It has raised $63.8 million.

Last reported valuation

$8.5M

Oct 2026

Priced at

—

Total raised

$63.8M

Last round

—

How much has LeadingTac raised?

$63.8Macross 0 recorded rounds

Free account

More of LeadingTac with a free account

·Watch LeadingTac: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

LeadingTac investors

8 investors are on record for LeadingTac, including CDH Investments, YuanBio Venture Capital, Lapam Capital and Hankang Capital.

For fundraisers

Raising for a company like LeadingTac?

8 investors have backed LeadingTac.

See all 8 investors →

Frequently asked about LeadingTac

How much has LeadingTac raised?: LeadingTac has raised $63.8M in total across 0 recorded funding rounds.